Stryker logo

Stryker dividend yield (ttm)NYSE: SYK

Dividend yield (TTM)

0.88%
-0.01%-1.12%

7 min ago

-38.46%vs 3 years high
+31.34%vs 3 years low
29.63%vs. sector
Performance
Most recent-1.1%
1 year-22.1%
3 years-3.3%
5 years-10.2%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
SYK-1.1%
SNY+0.3%
MDT+1.0%
PFE+1.0%
GILD-2.0%
1 year change
SYK-22.1%
SNY+6.3%
MDT-20.2%
PFE+9.0%
GILD-9.4%
3 years change
SYK-3.3%
SNY0.0%
MDT+54.3%
PFE+62.7%
GILD-17.5%
5 years change
SYK-10.2%
SNY+2.9%
MDT+53.5%
PFE+42.1%
GILD-7.5%

Dividend yield (TTM) performance

SYKSNYBSXVRTXMDTPFEGILD
Most recent-1.1%+0.3%--+1.0%+1.0%-2.0%
1 year-22.1%+6.3%---20.2%+9.0%-9.4%
3 years-3.3%0.0%--+54.3%+62.7%-17.5%
5 years-10.2%+2.9%--+53.5%+42.1%-7.5%
FAQ

What is Stryker dividend yield (ttm)?

Stryker dividend yield (ttm) is 0.88%

What is Stryker dividend yield (ttm) compared to its 3-years maximum value?

Stryker dividend yield (ttm) is 61.54% of its 3-years maximum value

What is Stryker dividend yield (ttm) compared to other companies from its sector (Healthcare)?

Stryker dividend yield (ttm) is higher than 29.63% of the companies in the same sector (Healthcare)

How has Stryker dividend yield (ttm) changed over the year?

Over the past year, Stryker dividend yield (ttm) has dropped by 22.1%. During the same period, Sanofi has increased by 6.3%, Medtronic has dropped by 20.2%, Pfizer has risen by 9.0%, Gilead Sciences has gone down by 9.4%

How has Stryker dividend yield (ttm) changed over the 3 years?

During the last 3 years, Stryker dividend yield (ttm) has dropped by 3.3%. Over the same period, Sanofi has not changed, Medtronic has increased by 54.3%, Pfizer has risen by 62.7%, Gilead Sciences has gone down by 17.5%

How has Stryker dividend yield (ttm) changed over the 5 years?

For the past 5 years, Stryker dividend yield (ttm) has dropped by 10.2%. In the same period, Sanofi has increased by 2.9%, Medtronic has increased by 53.5%, Pfizer has risen by 42.1%, Gilead Sciences has gone down by 7.5%